Evolent Health, Inc. financial data

Symbol
EVH on NYSE
Location
Arlington, VA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 25 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 112% % 14%
Debt-to-equity 193% % 51%
Return On Assets -23% % -831%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 111,638,338 shares -4.9%
Entity Public Float $1,300,000,000 USD -41%
Common Stock, Value, Issued $1,176,000 USD 0.86%
Weighted Average Number of Shares Outstanding, Basic 114,208,000 shares -0.41%
Weighted Average Number of Shares Outstanding, Diluted 114,208,000 shares -0.41%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $1,876,229,000 USD -27%
Cost of Revenue $1,476,346,000 USD -33%
Costs and Expenses $2,286,367,000 USD -12%
Operating Income (Loss) $410,138,000 USD -913%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $534,636,000 USD -748%
Income Tax Expense (Benefit) $126,000 USD 91%
Net Income (Loss) Attributable to Parent $534,510,000 USD -767%
Earnings Per Share, Basic -5.15 USD/shares -528%
Earnings Per Share, Diluted -5.15 USD/shares -528%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $151,856,000 USD 46%
Accounts Receivable, after Allowance for Credit Loss, Current $309,861,000 USD -25%
Assets, Current $506,372,000 USD -17%
Property, Plant and Equipment, Net $80,785,000 USD 10%
Operating Lease, Right-of-Use Asset $4,373,000 USD -29%
Intangible Assets, Net (Excluding Goodwill) $584,937,000 USD -14%
Goodwill $694,482,000 USD -39%
Assets $1,899,236,000 USD -25%
Accounts Payable, Current $59,776,000 USD -38%
Employee-related Liabilities, Current $50,987,000 USD 51%
Accrued Liabilities, Current $65,755,000 USD -0.91%
Contract with Customer, Liability, Current $1,203,000 USD -52%
Liabilities, Current $385,260,000 USD -46%
Contract with Customer, Liability, Noncurrent $110,000 USD
Deferred Income Tax Liabilities, Net $7,506,000 USD -31%
Operating Lease, Liability, Noncurrent $3,818,000 USD -85%
Other Liabilities, Noncurrent $8,012,000 USD 168%
Liabilities $1,484,042,000 USD 9.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax $2,624,000 USD -50%
Retained Earnings (Accumulated Deficit) $1,315,327,000 USD -68%
Stockholders' Equity Attributable to Parent $415,194,000 USD -59%
Liabilities and Equity $1,899,236,000 USD -25%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $4,565,000 USD -7%
Net Cash Provided by (Used in) Financing Activities $107,854,000 USD 625%
Net Cash Provided by (Used in) Investing Activities $13,093,000 USD -35%
Common Stock, Shares Authorized 750,000,000 shares 0%
Common Stock, Shares, Issued 117,603,806 shares 0.88%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $99,349,000 USD 891%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $180,696,000 USD 1.2%
Deferred Tax Assets, Valuation Allowance $74,878,000 USD 57%
Deferred Tax Assets, Gross $221,373,000 USD 14%
Operating Lease, Liability $19,161,000 USD -63%
Depreciation $26,300,000 USD -13%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $580,272,000 USD -518%
Lessee, Operating Lease, Liability, to be Paid $20,102,000 USD -63%
Property, Plant and Equipment, Gross $286,559,000 USD 13%
Operating Lease, Liability, Current $15,343,000 USD -43%
Lessee, Operating Lease, Liability, to be Paid, Year Two $2,187,000 USD -88%
Lessee, Operating Lease, Liability, to be Paid, Year One $15,786,000 USD -43%
Operating Lease, Weighted Average Discount Rate, Percent 0.0889 pure -2.2%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $941,000 USD -62%
Lessee, Operating Lease, Liability, to be Paid, Year Three $972,000 USD -68%
Deferred Tax Assets, Operating Loss Carryforwards $138,795,000 USD 11%
Unrecognized Tax Benefits $2,722,000 USD 6.9%
Lessee, Operating Lease, Liability, to be Paid, Year Four $548,000 USD -69%
Additional Paid in Capital $1,793,398,000 USD -0.58%
Amortization of Intangible Assets $89,600,000 USD 1.7%
Depreciation, Depletion and Amortization $24,058,000 USD -18%
Deferred Tax Assets, Net of Valuation Allowance $146,495,000 USD 0.56%
Share-based Payment Arrangement, Expense $39,739,000 USD -0.02%
Interest Expense $47,307,000 USD 80%